These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23585389)

  • 1. Specific antibodies against vaccine-preventable infections: a mother-infant cohort study.
    Jones C; Pollock L; Barnett SM; Battersby A; Kampmann B
    BMJ Open; 2013; 3(4):. PubMed ID: 23585389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses.
    Zimmermann P; Perrett KP; Messina NL; Donath S; Ritz N; van der Klis FRM; Curtis N
    EClinicalMedicine; 2019 Aug; 13():21-30. PubMed ID: 31517260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between concentration of specific antibody at birth and subsequent response to primary immunization.
    Jones C; Pollock L; Barnett SM; Battersby A; Kampmann B
    Vaccine; 2014 Feb; 32(8):996-1002. PubMed ID: 24342250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants.
    Jones CE; Naidoo S; De Beer C; Esser M; Kampmann B; Hesseling AC
    JAMA; 2011 Feb; 305(6):576-84. PubMed ID: 21304083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
    Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
    Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
    Ladhani SN; Andrews NJ; Southern J; Jones CE; Amirthalingam G; Waight PA; England A; Matheson M; Bai X; Findlow H; Burbidge P; Thalasselis V; Hallis B; Goldblatt D; Borrow R; Heath PT; Miller E
    Clin Infect Dis; 2015 Dec; 61(11):1637-44. PubMed ID: 26374816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy - a prospective, observational cohort study from the United Kingdom.
    Rice TF; Diavatopoulos DA; Smits GP; van Gageldonk PGM; Berbers GAM; van der Klis FR; Vamvakas G; Donaldson B; Bouqueau M; Holder B; Kampmann B
    Clin Exp Immunol; 2019 Jul; 197(1):1-10. PubMed ID: 30758857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired haemophilus influenzae type b transplacental antibody transmission and declining antibody avidity through the first year of life represent potential vulnerabilities for HIV-exposed but -uninfected infants.
    Gaensbauer JT; Rakhola JT; Onyango-Makumbi C; Mubiru M; Westcott JE; Krebs NF; Asturias EJ; Fowler MG; McFarland E; Janoff EN
    Clin Vaccine Immunol; 2014 Dec; 21(12):1661-7. PubMed ID: 25298109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial.
    Wood N; Nolan T; Marshall H; Richmond P; Gibbs E; Perrett K; McIntyre P
    JAMA Pediatr; 2018 Nov; 172(11):1045-1052. PubMed ID: 30208475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed BCG immunization does not alter antibody responses to EPI vaccines in HIV-exposed and -unexposed South African infants.
    Hesseling AC; Blakney AK; Jones CE; Esser MM; de Beer C; Kuhn L; Cotton MF; Jaspan HB
    Vaccine; 2016 Jul; 34(32):3702-9. PubMed ID: 27055019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis antibody levels in infants and their mothers receiving combined tetanus-diphtheria toxoid and acellular pertussis vaccine during pregnancy in Turkey.
    Ozdil M; Sonmez C; Tugberk Bakar M; Alici Davutoglu E; Madazli R; Kilic S; Vural M; Perk Y
    Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():212-216. PubMed ID: 34534737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of antibodies specific to diphtheria toxoid, tetanus toxoid, and Haemophilus influenzae type b in healthy children born to Tdap-vaccinated mothers.
    Wanlapakorn N; Maertens K; Thongmee T; Srimuan D; Thatsanathorn T; Van Damme P; Leuridan E; Poovorawan Y
    Vaccine; 2020 Oct; 38(44):6914-6921. PubMed ID: 32888740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.
    Schmitt HJ; Zepp F; Müschenborn S; Sümenicht G; Schuind A; Beutel K; Knuf M; Bock HL; Bogaerts H; Clemens R
    Eur J Pediatr; 1998 Mar; 157(3):208-14. PubMed ID: 9537487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at 2, 4 and 6 months of age.
    Arístegui J; Dal-Ré R; Garrote E; González A; Arrate JP; Pérez A
    Vaccine; 1998 Dec; 16(20):1976-81. PubMed ID: 9796053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial.
    Wanlapakorn N; Maertens K; Vongpunsawad S; Puenpa J; Tran TMP; Hens N; Van Damme P; Thiriard A; Raze D; Locht C; Poovorawan Y; Leuridan E
    Clin Infect Dis; 2020 Jun; 71(1):72-80. PubMed ID: 31418814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation.
    Slack MH; Cade S; Schapira D; Thwaites RJ; Crowley-Luke A; Southern J; Borrow R; Miller E
    Arch Dis Child; 2005 Apr; 90(4):338-41. PubMed ID: 15781918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life.
    Reikie BA; Naidoo S; Ruck CE; Slogrove AL; de Beer C; la Grange H; Adams RC; Ho K; Smolen K; Speert DP; Cotton MF; Preiser W; Esser M; Kollmann TR
    Clin Vaccine Immunol; 2013 Jan; 20(1):33-8. PubMed ID: 23114697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia.
    Mulholland K; Suara RO; Siber G; Roberton D; Jaffar S; N'Jie J; Baden L; Thompson C; Anwaruddin R; Dinan L; Glezen WP; Francis N; Fritzell B; Greenwood BM
    JAMA; 1996 Apr; 275(15):1182-8. PubMed ID: 8609686
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.